(Q52840224)
English
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme
scientific article published on 26 July 2007
Statements
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humans (English)
Mingxin Qian
Stephen A Bai
Bernice Brogdon
Jing-Tao Wu
Rui-Qin Liu
Maryanne B Covington
Kris Vaddi
Robert C Newton
Michael J Fossler
C Edwin Garner
Yuzhong Deng
Thomas Maduskuie
James Trzaskos
Carl P Decicco
David D Christ